Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
33.56 USD | +3.36% | +3.55% | +55.95% |
04-19 | Sector Update: Health Care Stocks Steady Pre-Bell Friday | MT |
04-19 | Spyre Therapeutics Files Mixed-Securities Shelf Registration for About 33.4 Million Shares | MT |
Evolution of the average Target Price on Spyre Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Spyre Therapeutics, Inc.
Stifel Nicolaus | |
Wells Fargo Securities | |
BTIG | |
Jefferies & Co. | |
LifeSci Capital | |
JonesTrading Institutional Services | |
Piper Sandler | |
Needham & Co. | |
HC Wainwright |
EPS Revisions
- Stock Market
- Equities
- SYRE Stock
- Consensus Spyre Therapeutics, Inc.